RECRUITING

Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care on physical activity and capacity, frailty and muscle mass, and quality of life.

Official Title

Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

Quick Facts

Study Start:2024-08-14
Study Completion:2028-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06291922

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. ≥ 18 years of age
  2. 2. Newly implanted with a HeartMate 3™ LVAD for the first time
  3. 3. Able to ambulate independently (with or without the use of an assistive device)
  4. 4. Owns a smartphone with Internet connection
  5. 5. Patient will be discharged home with LVAD or patient will be living at home with LVAD within 45 days of index discharge
  1. 1. Major comorbidities or limitations that may interfere with exercise training (including significant orthopedic/neurologic limitations, decompensated heart failure, uncontrolled arrhythmias, unstable angina)

Contacts and Locations

Study Contact

Clinical Research Coordinator
CONTACT
215-615-4481
asia.vincent@pennmedicine.upenn.edu

Principal Investigator

Himabindu Vidula, MD
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

Henry Ford Health
Detroit, Michigan, 48202
United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States
University of Utah Health
Salt Lake City, Utah, 84112
United States

Collaborators and Investigators

Sponsor: University of Pennsylvania

  • Himabindu Vidula, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-14
Study Completion Date2028-06-30

Study Record Updates

Study Start Date2024-08-14
Study Completion Date2028-06-30

Terms related to this study

Keywords Provided by Researchers

  • Left ventricular assist device
  • Exercise
  • Ventricular assist device
  • HeartMate 3 (HM3)

Additional Relevant MeSH Terms

  • Heart Failure